» Articles » PMID: 37646089

Mammalian Display to Secretion Switchable Libraries for Antibody Preselection and High Throughput Functional Screening

Overview
Journal MAbs
Date 2023 Aug 30
PMID 37646089
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, there has been a co-evolution of mammalian libraries and diverse microfluidic approaches for therapeutic antibody hit discovery. Mammalian libraries enable the preservation of full immune repertoires, produce hit candidates in final format and facilitate broad combinatorial bispecific antibody screening, while several available microfluidic methodologies offer opportunities for rapid high-content screens. Here, we report proof-of-concept studies exploring the potential of combining microfluidic technologies with mammalian libraries for antibody discovery. First, antibody secretion, target co-expression and integration of appropriate reporter cell lines enabled the selection of acting agonistic bispecific antibodies. Second, a functional screen for internalization was established and comparison of autocrine versus co-encapsulation setups highlighted the advantages of an autocrine one cell approach. Third, synchronization of antibody-secreting cells prior to microfluidic screens reduced assay variability. Furthermore, a display to secretion switchable system was developed and applied for pre-enrichment of antibody clones with high manufacturability in conjunction with subsequent screening for functional properties. These case studies demonstrate the system's feasibility and may serve as basis for further development of integrated workflows combining manufacturability sorting and functional screens for the identification of optimal therapeutic antibody candidates.

Citing Articles

Quantifying antibody binding: techniques and therapeutic implications.

Lodge J, Kajtar L, Duxbury R, Hall D, Burley G, Cordy J MAbs. 2025; 17(1):2459795.

PMID: 39957177 PMC: 11834528. DOI: 10.1080/19420862.2025.2459795.


Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects.

Slavny P, Hegde M, Doerner A, Parthiban K, McCafferty J, Zielonka S Front Immunol. 2024; 15:1469329.

PMID: 39381002 PMC: 11459229. DOI: 10.3389/fimmu.2024.1469329.


A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody-Drug Conjugates.

Barron N, Dickgiesser S, Fleischer M, Bachmann A, Klewinghaus D, Hannewald J Int J Mol Sci. 2024; 25(4).

PMID: 38396776 PMC: 10889805. DOI: 10.3390/ijms25042097.

References
1.
Makowski E, Kinnunen P, Huang J, Wu L, Smith M, Wang T . Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space. Nat Commun. 2022; 13(1):3788. PMC: 9249733. DOI: 10.1038/s41467-022-31457-3. View

2.
Zhou C, Jacobsen F, Cai L, Chen Q, Shen W . Development of a novel mammalian cell surface antibody display platform. MAbs. 2010; 2(5):508-18. PMC: 2958572. DOI: 10.4161/mabs.2.5.12970. View

3.
Huhtinen O, Salbo R, Lamminmaki U, Prince S . Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform. Front Bioeng Biotechnol. 2023; 11:1170081. PMC: 10203562. DOI: 10.3389/fbioe.2023.1170081. View

4.
Robertson N, Lopez-Anton N, Gurjar S, Khalique H, Khalaf Z, Clerkin S . Development of a novel mammalian display system for selection of antibodies against membrane proteins. J Biol Chem. 2020; 295(52):18436-18448. PMC: 7939478. DOI: 10.1074/jbc.RA120.015053. View

5.
Waldmeier L, Hellmann I, Gutknecht C, Wolter F, Cook S, Reddy S . Transpo-mAb display: Transposition-mediated B cell display and functional screening of full-length IgG antibody libraries. MAbs. 2016; 8(4):726-40. PMC: 4966844. DOI: 10.1080/19420862.2016.1160990. View